
Cass is a conversational AI platform designed to increase access to behavioral health and chronic disease management care. Leveraging AI, Cass engages visitors through text messaging and HIPAA-compliant apps, initiating conversations with a simple 'How are you?' to guide users through a process similar to an enrollment coordinator. The platform aims to overcome barriers to care such as stigma, cost, and wait times. Cass offers several products: Cass Support for direct user engagement, Cass Engage for nurturing qualified users and answering questions, Cass Copilot for live chat with human agents, and Cass Signals for surfacing user insights. The company's AI is built on extensive research, including millions of conversations and clinical assessments, and is designed to be empathetic, clinically proven, and available 24/7. Cass is trusted by leading healthcare providers and health insurance companies.

Cass is a conversational AI platform designed to increase access to behavioral health and chronic disease management care. Leveraging AI, Cass engages visitors through text messaging and HIPAA-compliant apps, initiating conversations with a simple 'How are you?' to guide users through a process similar to an enrollment coordinator. The platform aims to overcome barriers to care such as stigma, cost, and wait times. Cass offers several products: Cass Support for direct user engagement, Cass Engage for nurturing qualified users and answering questions, Cass Copilot for live chat with human agents, and Cass Signals for surfacing user insights. The company's AI is built on extensive research, including millions of conversations and clinical assessments, and is designed to be empathetic, clinically proven, and available 24/7. Cass is trusted by leading healthcare providers and health insurance companies.
What they do: Conversational AI platform for behavioral health and chronic disease management
Headcount: 97 employees
Recent funding: $4.6M reported (Oct 2022), lead PivotNorth Capital
Founded / rebrand: Rebranded from X2AI to Cass in August 2022
Behavioral health and chronic disease management access and engagement
Healthcare technology
$4.6M
Round reported Oct 2022; some profiles label the round differently (Seed vs Series A) and Crunchbase shows amount obfuscated.
“Tim Connors listed as investor and board member”